Make an appointment with a cancer specialist today.
Call us at 800-KARMANOS (800-527-6266)


Karmanos Cancer Institute Receives Generous Donation for Immunotherapy Program

Denis Kobus (son), Nick Karmanos, senior vice president, Institutional Relations, Maxim Yankelevich, M.D., Pediatric Hematology/Oncology, Wayne State University, Children's Hospital of Michigan, Lawrence Lum, M.D., D. Sc., professor of Medicine and Immunology and Microbiology at Karmanos and Wayne State University School of Medicine, Nicolai Kobus

Lawrence Lum, M.D., accepts a special donation of $20,000 in support of the immunotherapy program at Karmanos Cancer Institute from Mr. Nicolai Kobus. Mr. Kobus came to Karmanos from Russia via the referral of Maxim Yankelevich, M.D, a pediatric hematology oncologist at Children's Hospital of Michigan. Mr. Kobus is a close friend of Dr. Yankelevich's family in Russia. As a member of the KCI Immunotherapy team, Dr. Yankelevich spoke with Mr. Kobus about this emerging field of cancer therapy. Immunotherapy is a form of targeted therapy directed at specific cancer cell markers.

Mr. Kobus decided to travel to Detroit to receive adoptive T cell immunotherapy, involving infusions of anti-EGFR armed T cells for the treatment of his colon cancer. Mr. Kobus and his son Denis expressed appreciation for the opportunity to participate in this pioneering protocol developed at Karmanos. They decided to make a donation that will help other patients who may benefit from this novel therapy. "Individuals like Mr. Kobus help us advance the innovative cancer research that we conduct here at the Institute," said Nick Karmanos, senior vice president of Institutional Relations at Karmanos. "Our physician scientists are committed to offering the most effective and advanced cancer therapies so that each and every patient is given their best chance at a cure. We are inspired by Mr. Kobus' courage and compassion and deeply grateful for this thoughtful gift to our immunotherapy program."

Minsig Choi, M.D., who is the principal investigator of the targeted T cell protocol, is managing Mr. Kobus' care with members of the immunotherapy team led by Dr. Lum.

© 2014 Karmanos Cancer Institute Pencil
The Barbara Ann Karmanos Cancer Center is accredited by The Joint Commission.
If members of the public have any quality-of-care or safety concerns, they may notify The Joint Commission at 630-792-5800.